000 | 01729 a2200493 4500 | ||
---|---|---|---|
005 | 20250516184625.0 | ||
264 | 0 | _c20140818 | |
008 | 201408s 0 0 eng d | ||
022 | _a1872-6240 | ||
024 | 7 |
_a10.1016/j.brainres.2013.12.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Xin-ran | |
245 | 0 | 0 |
_aNeuroprotective effect of chondroitinase ABC on primary and secondary brain injury after stroke in hypertensive rats. _h[electronic resource] |
260 |
_bBrain research _cJan 2014 |
||
300 |
_a324-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain Infarction _xpathology |
650 | 0 | 4 |
_aBrain Injuries _xdrug therapy |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 |
_aChondroitin ABC Lyase _xtherapeutic use |
650 | 0 | 4 |
_aChondroitin Sulfate Proteoglycans _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFunctional Laterality |
650 | 0 | 4 |
_aGAP-43 Protein _xmetabolism |
650 | 0 | 4 |
_aHypertension _xcomplications |
650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeurologic Examination |
650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
650 | 0 | 4 |
_aPhosphopyruvate Hydratase _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aLiao, Song-jie | |
700 | 1 | _aYe, Lan-xiang | |
700 | 1 | _aGong, Qiong | |
700 | 1 | _aDing, Qiao | |
700 | 1 | _aZeng, Jin-sheng | |
700 | 1 | _aYu, Jian | |
773 | 0 |
_tBrain research _gvol. 1543 _gp. 324-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2013.12.002 _zAvailable from publisher's website |
999 |
_c23355745 _d23355745 |